castle biosciences stock zacks

The Zacks Scorecard is a complimentary set of indicators to use alongside the Zacks Rank. Its used by Nasdaq Yahoo.

Castle Biosciences Inc 2022 Definitive Proxy Statement Def 14a

It allows the investor to better focus on the stocks that are the best fit for his or.

. Ad Experts trust Zacks research. Is currently rated as a Zacks Rank 3 and we are expecting an inline return from the CSTL shares relative to the. Castle Biosciences Inc.

It allows the investor to better focus on the stocks that are the best fit for his or her personal. The upgrade of Castle Biosciences Inc. CSTL came out with a quarterly loss of 034 per share versus the Zacks Consensus Estimate of a loss of 029.

Finance Forbes and others. To a Zacks Rank 1 positions it in the top 5 of the Zacks-covered stocks in terms of estimate revisions implying that the stock might. According to Zacks Castle Biosciences Inc.

Zacks proprietary data indicates that Castle Biosciences Inc. Is a commercial-stage dermatological cancer company. The Zacks Scorecard is a complimentary set of indicators to use alongside the Zacks Rank.

Check out Zacks stock rank on your favorite tickers today absolutely FREE. This compares to loss of 008 per. It is focused on providing physicians and patients clinically actionable.

Cstl Stock Forecast Price News Castle Biosciences